At a glance
- Originator Pfizer
- Class
- Mechanism of Action Endopeptidase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Heart failure; Hypertension
Most Recent Events
- 07 Apr 2000 Discontinued - Unspecified phase in Heart failure in USA (Unknown route)
- 07 Apr 2000 Discontinued - Unspecified phase in Hypertension in USA (Unknown route)
- 27 Jun 1995 No-Development-Reported for Heart failure in USA (Unknown route)